Looking beyond traditional markets

The United States is the world’s largest pharmaceutical market. Japan is the second largest, although the combined European Union is larger than the Japanese market (but smaller than the U.S.). Naturally, any company looking to sell drugs should focus on these markets, but there are reasons to reach out into smaller markets:

This article describes a strategy to reduce revenue risk by diversifying into markets with reduced regulatory and intellectual property oversight.

Comments are closed.